The Pharmaceutical Market Canada

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Anti-Infective Drug News 26 JANUARY 2015

Anti-Infective Drug News 26 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 16 pages

Industry Trend Analysis - US HCV Drug Pricing Battle To Extend To Europe Industry Brief - Roche/Meiji/Fedora Enter Collaboration For Development Of OP0595 Industry Brief - Valneva To Acquire Dukoral Vaccine From Crucell Industry Brief - Aradigm Granted Key Composition Of Matter Patents For Pulmaquin ...

Industries: Drug and Medication | Countries: United States, Canada, India, World, United Kingdom, Europe, North America

Tribute Pharmaceuticals Canada Inc

Tribute Pharmaceuticals Canada Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 55 pages

A textual analysis of the financial results for Tribute Pharmaceuticals Canada Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Pharmaceutical | Countries: Canada

Anti-Infective Drug News 12 JANUARY 2015

Anti-Infective Drug News 12 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 24 pages

Industry Trend Analysis - High NME FDA Approvals In 2014 Indicates New Era For Anti-Infectives Industry Brief - Xydalba Gains CHMP Positive Opinion For ABSSSIs In Adults Industry Brief - Zevtera Gains Swissmedic Approval For Pneumonia Industry Brief - Phylogica/Genentech Enter Collaboration For Novel ...

Industries: Drug and Medication | Countries: South Africa, Canada, Africa, World, United States, United Kingdom

Cardiometabolic Drug News JANUARY 2015

Cardiometabolic Drug News JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 9 pages

Industry Brief - X-Chem Licenses Cardiovascular Drug-Discovery Programme To Bayer Industry Brief - La Jolla/GWU Enter Licence Agreement Covering IP Relating To LJPC-501 Industry Brief - Lilly/Adocia To Co-Develop BioChaperone Technology-Based Ultra-Rapid Insulin Industry Brief - The Medicines Company/SciClone ...

Industries: Drug and Medication | Countries: China, Canada, Japan

BioSyent Inc. (Symbol:RX) SWOT Analysis, Strategy, Revenues and Profits

BioSyent Inc. (Symbol:RX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BioSyent Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Canada

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. GeneNews Limited SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, Canada, Malaysia, China

iCo Therapeutics Inc. (Symbol:ICO) SWOT Analysis, Strategy, Revenues and Profits

iCo Therapeutics Inc. (Symbol:ICO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. iCo Therapeutics Inc. SWOT Analysis report provides you a strategic ...

Industries: Therapy | Countries: Canada

Kane Biotech Inc. (KNE) - Financial and Strategic SWOT Analysis Review

Kane Biotech Inc. (KNE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary Kane Biotech Inc. (Kane Biotech) is a biotechnology company. The company develops and commercializes products that prevent and remove microbial biofilms. It uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt ...

Industries: Drug and Medication | Countries: Canada

Medicure Inc. (MPH) - Financial and Strategic SWOT Analysis Review

Medicure Inc. (MPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary Medicure Inc. (Medicure) is a pharmaceutical company. The company carries out research, clinical development and commercialization of human therapeutics. It offers products such as aggrastat and tardoxal. Medicure offers aggrastat to reduce the rate of thrombotic cardiovascular events (combined ...

Industries: Pathology | Countries: United States, Canada

Pacific Therapeutics Ltd. (PT) - Financial and Strategic SWOT Analysis Review

Pacific Therapeutics Ltd. (PT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary Pacific Therapeutics Ltd. (Pacific) is a pharmaceutical company. The company identifies, develops and sells drug candidates to treat diseases of the liver and lungs. Its product PTL-202 is a clinical trial product used to treat idiopathic pulmonary fibrosis. Pacific also develops PTL-303, a combination ...

Industries: Therapy | Countries: Canada

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.